Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1671
This examiner grants 35% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18080639 | VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES | Final Rejection | Janssen Biotech, Inc. |
| 18017955 | ADENOVIRUS VECTORS AND METHODS FOR USING ADENOVIRUS VECTORS | Final Rejection | Mayo Foundation for Medical Education and Research |
| 18262522 | PNMA2-BASED CAPSIDS AND USES THEREOF | Final Rejection | University Of Utah Research Foundation |
| 18000055 | ISCAN: AN RT-LAMP-COUPLED CRISPR-CAS MODULE FOR RAPID, SENSITIVE DETECTION OF SARS-COV-2 | Final Rejection | King Abdullah University of Science and Technology |
| 18255748 | A PROCESS AND A KIT FOR DETECTION OF CORONAVIRUS AND OTHER RESPIRATORY VIRUSES | Final Rejection | Council of Scientific and Industrial Research |
| 18555940 | A VACCINE ADJUVANT FOR INFECTIOUS DISEASES | Non-Final OA | University of Cincinnati |
| 18249999 | SARS-COV-2 ANTIBODIES AND USES THEREOF | Non-Final OA | Icahn School of Medicine at Mount Sinai |
| 18042448 | SINGLE-DOMAIN ANTIBODIES THAT BIND SARS-COV-2 | Non-Final OA | Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
| 17821411 | COMPOSITIONS AND METHODS FOR DETECTING SARS-CoV-2 | Final Rejection | The University of Hong Kong |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy